483
Deborah A. Goss, M.D.FDA 483 - Deborah A. Goss, M.D. - March 17, 2025
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of Deborah A. Goss, M.D. in Hackensack, NJ, revealed significant issues in the conduct and documentation of clinical investigations. The firm failed to adhere to its investigational plan, maintain complete records, and ensure the accuracy of subject case histories. Additionally, adverse device effects were not fully recorded or reported to the sponsor, indicating a lack of compliance with regulatory requirements for clinical trials.
Open in Dashboard
ID · 8d4466c5-aef8-474d-8617-05ea6c0f2a61